. .
Deutsch
Deutschland
Ähnliche Bücher
Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Suchtools
Anmelden

Anmelden mit Facebook:

Registrieren
Passwort vergessen?


Such-Historie
Merkliste
Links zu eurobuch.de

Dieses Buch teilen auf…
Buchtipps
Aktuelles
Tipp von eurobuch.de
Werbung
Bezahlte Anzeige
FILTER
- 0 Ergebnisse
Kleinster Preis: 149,75 €, größter Preis: 245,03 €, Mittelwert: 192,37 €
Therapeutic Kinase Inhibitors - Ingo K. Mellinghoff
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Ingo K. Mellinghoff:

Therapeutic Kinase Inhibitors - neues Buch

22, ISBN: 9783642282959

[ED: Buch], [PU: Springer-Verlag GmbH], Neuware - Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editorsinvited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authorshope these lessons will be instructive for the novice as well as the expert., [SC: 2.00]

Neues Buch Booklooker.de
buchversandmimpf2000
Versandkosten: EUR 2.00
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Therapeutic Kinase Inhibitors - Ingo K. Mellinghoff
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)

Ingo K. Mellinghoff:

Therapeutic Kinase Inhibitors - neues Buch

2012, ISBN: 9783642282959

[ED: Buch], [PU: Springer-Verlag GmbH], Neuware - Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editorsinvited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authorshope these lessons will be instructive for the novice as well as the expert., [SC: 0.00]

Neues Buch Booklooker.de
Carl Hübscher GmbH
Versandkosten:Versandkostenfrei (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Therapeutic Kinase Inhibitors - Mellinghoff Ingo K., Sawyers Charles L.
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Mellinghoff Ingo K., Sawyers Charles L.:
Therapeutic Kinase Inhibitors - gebunden oder broschiert

ISBN: 9783642282959

[ED: Gebunden], [PU: Springer-Verlag Gmbh], Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as chemotherapy and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editorsinvited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authorshope these lessons will be instructive for the novice as well as the expert. , [SC: 0.00]

Neues Buch Booklooker.de
Buecher-Dambeck
Versandkosten:Versandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Therapeutic Kinase Inhibitors - Ingo K. Mellinghoff; Charles L. Sawyers
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Ingo K. Mellinghoff; Charles L. Sawyers:
Therapeutic Kinase Inhibitors - gebunden oder broschiert

2012, ISBN: 9783642282959

ID: 22428658

2012, Hardcover, Buch, [PU: Springer Berlin]

Neues Buch Lehmanns.de
Versandkosten:Versand in 7-9 Tagen, , Versandkostenfrei innerhalb der BRD (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Therapeutic Kinase Inhibitors - Ingo K. Mellinghoff; Charles L. Sawyers
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Ingo K. Mellinghoff; Charles L. Sawyers:
Therapeutic Kinase Inhibitors - gebunden oder broschiert

2012, ISBN: 9783642282959

ID: 22428658

[ED: 2012], Hardcover, Buch, [PU: Springer Berlin]

Neues Buch Lehmanns.de
Versandkosten:Versand in 7-9 Tagen, , Versandkostenfrei innerhalb der BRD (EUR 0.00)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.

< zum Suchergebnis...
Details zum Buch
Therapeutic Kinase Inhibitors
Autor:

Ingo K. Mellinghoff

Titel:

Therapeutic Kinase Inhibitors

ISBN-Nummer:

9783642282959

Detailangaben zum Buch - Therapeutic Kinase Inhibitors


EAN (ISBN-13): 9783642282959
ISBN (ISBN-10): 3642282954
Gebundene Ausgabe
Erscheinungsjahr: 2012
Herausgeber: Springer-Verlag GmbH
234 Seiten
Gewicht: 0,492 kg
Sprache: Englisch

Buch in der Datenbank seit 22.02.2007 17:09:48
Buch zuletzt gefunden am 18.06.2016 14:22:23
ISBN/EAN: 9783642282959

ISBN - alternative Schreibweisen:
3-642-28295-4, 978-3-642-28295-9

< zum Suchergebnis...
< zum Archiv...
Benachbarte Bücher